Sorry, you need to enable JavaScript to visit this website.

Featured Stories

Real People

'Science Has Kept Me Here': How Biomarker Research is Shaping the Future of Cancer Care

Debbie Pickworth shares her journey and experience after receiving a lung cancer diagnosis.

Programs & Initiatives

Bridging the Gap: Community-Based Organizations Seek Trust, Tools and Funding to Advance Public Health

Community-based organizations (CBOs) are the cornerstone of community health—yet across the country they face substantial uncertainty, according to a new national survey supported by the Pfizer Multicultural Health Equity Collective (The Collective).

Science & Innovation

Pursuing the Next Breakthrough in Cancer Cachexia

Cachexia, a complex wasting syndrome, impacts an estimated 9 million people worldwide. Currently, there are no FDA-approved treatments targeting its underlying cause.

Press Releases

Categories

Keywords

  • All Keywords

January 2026

December 2025

November 2025

Resource Library

Press Kits

These downloadable files, including fact sheets about Pfizer and approved images or videos, are packages curated by the Global Media Relations team for use by professional journalists.

View Press Kits Details
Though intended for professional media, these resources may also be interesting to patients, healthcare professionals, and investors. The media relations team is focused on responding to media inquiries. However, we want to ensure that customers, investors, and others receive the appropriate attention.

For patients or healthcare professionals with questions about Pfizer’s vaccines or medicines, please see our global list of medical information contacts.

For investors with questions about Pfizer’s efforts, please visit our contact page and select "Shareholder Services".

For all other non-media inquiries, please visit the contact us page to reach the appropriate Pfizer contact.

Contact Pfizer Media Relations

Media Contacts

United States, Canada, and Latin America
+1 212.733.1226

Europe, Middle East, and Africa
+44-(0)845.300.8033

Asia Pacific
+65.918.732.47

Email
[email protected]